CIREN treats almost
100,000 patients
Iris Armas & Yicel
López
Some 100,000 people from 91
countries, the majority from Cuba, have been treated
at the International Center for Neurological
Restoration (CIREN), since its creation almost 25
years ago, today announced experts in Havana.
Dr. Emilio Villa Acosta, president
of CIREN commented that, since its founding – on
July 26 1989 - by leader of the Cuban Revolution
Fidel Castro, the institution has provided a unique
neurological restoration program that combines basic
and clinical research, medical diagnosis, treatment,
rehabilitation in all its forms and surgery.
CIREN is leader in its field in
Latin America and its work on the development of,
and treatment for, Parkinson’s disease as well as
epilepsy and dystonias has had a global impact.
Acosta highlighted that, the scientists at CIREN
also investigate autism, brain damage, head injuries
and medulla malfunction, among other illnesses.
The Center provides a multifaceted
and intensive neurological reconstruction program,
the only one of its kind in the world, which
improves the patient’s chances of a successful
recovery. Working on the program is a
multidisciplinary team, led by a neurologist and
made up of 13 medical and non-medical specialists
who attend to patients seven hours a day, from
Monday to Saturday, giving them thorough and
personalized care, he noted.
Villa Acosta stated that CIREN’s
research programs generate income which contributes
to the institution’s economic sustainability. In
line with the country’s Economic and Social Policy
Guidelines, it provides international services which
generate revenue, to fund new research.
Dr. Jorge Bergado, secretary of
CIREN’s scientific council, has announced the 4th
Conference for Neurological Restoration, which will
take place in March 2014 at Havana’s Convention
Center. Experts from various countries, including
France, Spain, the United States, Mexico and Chile
will be in attendance. He concluded that, Cuba will
discuss current issues in the field, and new
therapeutic strategies to control neurodegenerative
and brain disorders, among other topics.